Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods Results from multicenter trials
- 29 February 1996
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 24 (2) , 87-91
- https://doi.org/10.1016/0732-8893(95)00276-6
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers a reevaluation after five yearsDiagnostic Microbiology and Infectious Disease, 1995
- In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridoneAntimicrobial Agents and Chemotherapy, 1993
- Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agentsPublished by Elsevier ,1989
- RoxithromycinDrugs, 1989